NEW HAVEN PHARMACEUTICALS, INC.

Profile

Company Names

NEW HAVEN PHARMACEUTICALS, INC.

Addresses

116 WASHINGTON AVENUE, 4TH FLOOR, NORTH HAVEN, CT 06473

142 TEMPLE STREET, SUITE 205, NEW HAVEN, CT 06510

Phone Numbers

203-676-3676

 

Entity Type:

CORPORATION

Industry:

PHARMACEUTICALS

Year Incorporated:

2008

State Incorporated:

DELAWARE

Total Amount Raised:

$18,879,606.00

Number of Funding Rounds:

3
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
3
2016-08-01 
$602,222.00 
$1,301,736.00 
$699,514.00 
Debt 
2
2014-10-08 
$11,786,611.00 
$21,770,161.00 
$9,983,550.00 
Equity 
1
2012-09-19 
$6,490,773.00 
$7,706,688.00 
$1,215,915.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
LARRY 
 
DILLAHA 
DIRECTOR
INVASC THERAPEUTICS, INC.   |  INSYS THERAPEUTICS, INC.   |  NEW HAVEN PHARMACEUTICALS, INC.   |  AFFINIMARK TECHNOLOGIES INC   |  MELT PHARMACEUTICALS, INC.
CHRISTOPHER 
 
ECKLUND 
DIRECTOR
NEW HAVEN PHARMACEUTICALS, INC.
PATRICK 
 
FOURTEAU 
EXECUTIVE OFFICER, DIRECTOR, PROMOTER
INSYS THERAPEUTICS, INC.   |  NEW HAVEN PHARMACEUTICALS, INC.   |  AFFINIMARK TECHNOLOGIES INC
SCOTT 
 
KOZAK 
PROMOTER
NEW HAVEN PHARMACEUTICALS, INC.   |  ASSURE HOLDINGS CORP.
NANCY 
 
MOTOLA 
EXECUTIVE OFFICER
NEW HAVEN PHARMACEUTICALS, INC.
HARRY 
 
PENNER, JR. 
EXECUTIVE OFFICER, DIRECTOR, PROMOTER
NEW HAVEN PHARMACEUTICALS, INC.
HARRY 
H. 
PENNER, JR. 
EXECUTIVE OFFICER, DIRECTOR
MARINUS PHARMACEUTICALS INC   |  RIB X PHARMACEUTICALS INC   |  RIB-X PHARMACEUTICALS, INC.   |  CELLDEX THERAPEUTICS, INC.   |  AFFINIMARK TECHNOLOGIES INC   |  NEW HAVEN PHARMACEUTICALS, INC.   |  CELLDEX THERAPEUTICS, INC.
WILLIAM 
 
SESSA 
DIRECTOR
NEW HAVEN PHARMACEUTICALS, INC.   |  VST BIO CORP
THEODORE 
 
STANLEY 
DIRECTOR
NUVO RESEARCH INC   |  NEW HAVEN PHARMACEUTICALS, INC.
ROB 
 
STERLING 
PROMOTER
PREVENTION PHARMACEUTICALS, INC.   |  NEW HAVEN PHARMACEUTICALS, INC.
DANIEL 
 
WAGNER 
DIRECTOR
INNOVATIENT SOLUTIONS, INC.   |  REMOTEREALITY CORP   |  NEW HAVEN PHARMACEUTICALS, INC.   |  CMDBIOSCIENCE,INC.   |  SOFT TISSUE REGENERATION, INC.   |  ISOPLEXIS CORP   |  BARPAY, LLC   |  CORNOVUS PHARMACEUTICALS INC.   |  BIOREZ, INC.   |  AZITRA INC   |  ALLOMEK THERAPEUTICS, LLC   |  PROTEOWISE INC.   |  HASTE, INC.   |  TANGEN BIOSCIENCES, INC.   |  MITOTHERAPEUTIX, LLC   |  INTUS BIOSCIENCES, LLC   |  REZOLVE AI PLC   |  ENRICH BIOSYSTEMS INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2016-08-17
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Debt 
2016-08-01 
2014-10-23
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2014-10-08 
2012-10-02
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2012-09-19 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#